James Sapirstein
Board Member
Inmune Bio, Inc. (INMB)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About James Sapirstein
James Sapirstein is recorded as Board Member at Inmune Bio, Inc. (INMB). Inmune Bio, Inc. reported in an 8-K filed September 14, 2026 that James Sapirstein was appointed members of the Nominating and Corporate Governance Committee of the Board. Inmune Bio, Inc. reported in an 8-K filed September 14, 2026 that James Sapirstein was appointed directors of the Company, effective September 8, 2026.
“The Board also appointed Mr. Clark and Mr. Sapirstein to serve as members of the Nominating and Corporate Governance Committee of the Board.”
“On September 8, 2026, the Board of Directors (the “Board”) of INmune Bio, Inc. (the “Company”) approved to increase the number of directors and to set the number of directors serving on the Board at seven, and, pursuant to the Company’s by-Laws, appointed R. Duane Clark II and James Sapirstein to serve as directors of the Company until the next annual election and until their successors are duly elected and qualified.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-09-14–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Inmune Bio, Inc.
Other people whose current roles at this company are on record from its filings.
- David J. Moss CEO, Board Member
- J. Kelly Ganjei Chairman
- Cory Ellspermann Board Member
- David Moss Board Member
- Edgardo Baracchini, PhD Board Member
- Marcia Allen Board Member
- Mark Lowdell Board Member
- R. Duane Clark II Board Member
- Raymond J. Tesi, MD Board Member
- Scott Juda Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.